Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Now that the litigation between Moore and TPL is over-Still -ease

I tend to agree that the markets may not care. However, if Leckrone (take your pick which one) has been keeping agreements locked in the drawer awaiting an outcome with Moore, then perhaps we will begin to see that wave of licenses again, followed by an announcement by PTSC that they will implement the dividend again. This year's shareholder meeting might prove to be better than the last one or two.

Share
New Message
Please login to post a reply